20 January 2021>: Database AnalysisMaoshu Zhu 1AB* , Jiading Cai 2C* , Yulong Wu 3D , Xinhong Wu 4E , Lianghua Feng 5AF* , Zhijiang Yin 6AG
Med Sci Monit 2021; 27:e928195
Figure 8 Verification of molecular subtypes for gastric cancer in the validation set. (A, B) NMF clustering results for prognosis-related RBPs. (C) PCA results. (D) Overall survival analysis for 2 molecular subtypes. (E) Gene expression signatures of 2 distinct molecular subtypes.